Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2012
10/17/2012CN101748151B Recombinant human hepatitis C virus antigen adenoviral vector and applications thereof
10/17/2012CN101695511B Pomegranate rind extract and production method and application thereof
10/17/2012CN101691405B Fusion antigen uses as vaccine
10/17/2012CN101683423B Application of Chinese medicine composition in preparation of medicament for treating chicken pox
10/17/2012CN101631553B Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
10/17/2012CN101605548B Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection
10/17/2012CN101548958B Dispersing tablet containing terbinafine hydrochloride
10/17/2012CN101466727B Hcv/hiv inhibitor and their uses
10/17/2012CN101412692B 1-(3-amino propyl) piperidine-4-aminoamide compounds, and pharmaceutical composition, preparation and use thereof
10/17/2012CN101297882B Chinese medicine preparation for treating infectious serositis of duck and preparation method thereof
10/17/2012CN101219216B Method for preparing coexpression PRRSV ORF3 and ORF5 double-gene nucleic acid vaccine
10/17/2012CN101219195B Pharmaceutical composition, pharmaceutical formulation containing the composition and and uses thereof
10/16/2012USRE43748 Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same
10/16/2012US8288570 7-iodo tetracyclines and related methods
10/16/2012US8288560 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
10/16/2012US8288539 Dipeptidyl peptidase inhibitors
10/16/2012US8288537 Caspase inhibitors and uses thereof
10/16/2012US8288528 Meso-substituted porphyrins
10/16/2012US8288439 Attenuation of reproduction in human cells or transmission of infections ; using polynucleotide
10/16/2012US8288125 Intergenic regions as insertion sites in the genome of modified vaccinia virus Ankara (MVA)
10/16/2012US8287884 Staphylococcus aureus proteins and nucleic acids
10/16/2012US8287883 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof
10/16/2012US8287877 Composition comprising immunogenic microparticles
10/16/2012US8287849 Biodegradable poly(beta-amino esters) and uses thereof
10/16/2012CA2670103C Inhibitors of hiv replication
10/16/2012CA2634992C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
10/16/2012CA2627430C Growth control of oral and superficial microorganisms using gallium compounds
10/16/2012CA2561635C New crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
10/16/2012CA2544155C Drug and method for proliferating natural killer cells
10/16/2012CA2523854C Crystals of quinolinecarboxylic acid derivative solvate
10/16/2012CA2466773C Inhibitor oligonucleotides and their use for specific repression of a gene
10/16/2012CA2457804C Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
10/16/2012CA2412498C Non-human animal models of tolerance to hepatitis c virus immunogenes
10/16/2012CA2356257C Insulin-like growth factor (igf) i mutant variants
10/11/2012WO2012139112A1 Ubiquitin fusions for improving the efficacy of cytosolic acting targeted toxins
10/11/2012WO2012139106A2 Herpes simplex virus
10/11/2012WO2012139081A2 Methods for treating conditions associated with masp-2 dependent complement activation
10/11/2012WO2012138911A2 Conjugates of anti-hiv drugs and somatostatin analogs
10/11/2012WO2012138669A1 Solid state forms of hiv inhibitor
10/11/2012WO2012138477A2 Probiotic bacterial strains and method of use to decrease mortality due to bacterial disease
10/11/2012WO2012137538A1 Cytotoxic t cell inducing composition
10/11/2012WO2012137479A1 Peptide which can induce antibody capable of recognizing stereostructure of hiv
10/11/2012WO2012137166A1 An oxoborolidine compound and uses thereof
10/11/2012WO2012137164A1 Antimicrobial compositions, antibiofilm compositions and uses thereof
10/11/2012WO2012137142A1 Novel salts of raltegravir
10/11/2012WO2012137099A1 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
10/11/2012WO2012137072A1 Therapeutic vaccine compositions inducing tolerance to hiv for treating hiv infections in humans
10/11/2012WO2012136149A1 Euphorbia of anti latent hiv and the uses thereof
10/11/2012WO2012136111A1 Phenylpropionic acid compound, preparation method therefor and medicinal use thereof
10/11/2012WO2012135959A1 Protease cleavage site peptides as an hiv vaccine
10/11/2012WO2012097185A3 Omv vaccine against burkholderia infections
10/11/2012WO2012085171A3 Pharmaceutical compositions of pyridinium and quinolinium derivatives
10/11/2012WO2012083058A3 Anti-viral compounds
10/11/2012US20120260358 Aptamer capable of binding to viral hemorrhagic septicemia virus
10/11/2012US20120260356 Meganuclease variants cleaving at least one target in the genome of a retrovirus and uses thereof
10/11/2012US20120259151 Pyridopyrazine derivatives and their use
10/11/2012US20120259095 Monoclonal antibodies with enhanced adcc function
10/11/2012US20120259014 Topical retnoid solutions
10/11/2012US20120258986 Olefin containing nuclear transport modulators and uses thereof
10/11/2012US20120258980 Antibacterial Agent for Drug-Resistant Bacteria, Method for Screening for Same, and Use of Same
10/11/2012US20120258975 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof
10/11/2012US20120258972 Composition and Methods for Treating Hair Loss
10/11/2012US20120258969 Viral inhibitors
10/11/2012US20120258968 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
10/11/2012US20120258960 Novel multifunctional peptidase inhibitors, especially for medical use
10/11/2012US20120258959 Pyridone gpr119 g protein-coupled receptor agonists
10/11/2012US20120258949 Spirocyclic derivatives as histone deacetylase inhibitors
10/11/2012US20120258948 N-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents
10/11/2012US20120258936 Inositol hexakisphosphate analogs and uses thereof
10/11/2012US20120258935 Process for preparation of hiv protease inhbitors
10/11/2012US20120258934 Fosfomycin pharmaceutical composition
10/11/2012US20120258928 Nucleoside cyclicphosphates
10/11/2012US20120258925 Antibacterial aminoglycoside analogs
10/11/2012US20120258911 Phenylalkylcarboxylic acid delivery agents
10/11/2012US20120258909 Solid Compositions
10/11/2012US20120258908 Oligoadenylate synthetase (oas)
10/11/2012US20120258907 Treatment of fungal and/or protist infections
10/11/2012US20120258906 Use of peptides as antidandruff agents
10/11/2012US20120258453 Nucleic acid probe-based diagnostic assays targeting ssra genes of prokaryotic and eukaryotic organisms
10/11/2012US20120258177 Microcapsules comprising benzoyl peroxide and topical compositions comprising them
10/11/2012US20120258176 Nanoparticles for protein drug delivery
10/11/2012US20120258174 Methods for Treating Bacterial Infection
10/11/2012US20120258169 Chewable Soft Capsule
10/11/2012US20120258166 Rifaximin compositions and method of use
10/11/2012US20120258162 Controlled delivery of molecules from a biointerface
10/11/2012US20120258149 Methods and Compositions for the Prevention and Treatment of Influenza
10/11/2012US20120258147 Method for inhibiting angiogenesis
10/11/2012US20120258141 Methods Of Immune Modulation
10/11/2012US20120258139 Attenuated Live Vaccines for Aquatic Animals
10/11/2012US20120258138 Probiotic bacterial strains and method of use to decrease mortality in fish due to bacterial disease
10/11/2012US20120258137 Immunogenic compositions comprising nanoemulsion and hepatitis b virus immunogen and methods of using the same
10/11/2012US20120258136 Methods for cultivating cells, propagating and purifying viruses
10/11/2012US20120258134 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
10/11/2012US20120258133 Construct
10/11/2012US20120258129 Mycobacterium tuberculosis fusion protein and uses thereof
10/11/2012US20120258128 Infection Factor Assay
10/11/2012US20120258127 Vaccine peptides
10/11/2012US20120258126 Molecular Vaccines for Infectious Disease
10/11/2012US20120258124 Antigen-antibody complexes as hiv-1 vaccines
10/11/2012US20120258114 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 1798